Viewing Study NCT02165202


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-02-25 @ 8:31 PM
Study NCT ID: NCT02165202
Status: COMPLETED
Last Update Posted: 2018-08-27
First Post: 2014-05-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Sponsor: PATH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Immunodeficiency Virus (HIV) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV Pre-exposure Prophylaxis; View
None long-acting injectable; View
None HIV PrEP; View
None biomedical HIV prevention research View